SM

Sandy Mahatme

Non-Executive Member at Idorsia

Sandy Mahatme is currently a non-executive member of Idorsia. Prior to this, they served as the chief financial officer and chief business officer of Sarepta Therapeutics from 2012 to 2020. Before that, they were at Celgene Corporation from 2006 to 2012, where they were the senior vice president of corporate strategic development and initiatives. Sandy began their career at Pfizer Inc. in 1997 as senior counsel and held that position until 2006 when they joined Celgene.

Sandy Mahatme attended Cornell Law School and NYU Law School.

Timeline

  • Non-Executive Member

    May 13, 2020 - present